Safety Innovations and Discovery of New Niches Set the U.S. IV Therapy Market on the Move

September 27, 2018

By Andrew Ignatov and Kamran Zamanian, Ph.D., iData Research Inc.


For the last 40 years, intravenous (IV) infusion therapy became as ubiquitous as cots and syringes. In the U.S., for every hospital bed, there are almost 2 electronic IV pumps used. Therefore, over the past few years, this has saturated market. However, this proved to be an arena for steady sales growth for both market leaders and technology innovators. The main challenge facing health care providers and device manufacturers is how to make this therapy safer but also more accessible.

Share on Facebook
Share on Twitter
Please reload

Featured Posts

Dive Into Summer Now!

July 9, 2019

Please reload

Recent Posts

May 16, 2019

January 15, 2019

Please reload

Please reload

Search By Tags